Medical research funding cuts are sending shockwaves through the healthcare community, jeopardizing ongoing efforts to protect patient safety.With more than $2 billion in federal research grants suspended due to recent governmental actions, many crucial clinical trials and oversight initiatives face significant delays and interruptions.